REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Nefrofarm OOO (Нефрофарм ООО) (Russia)

Main Activities: Hospitals
Full name: Nefrofarm OOO Profile Updated: October 16, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

Nefrofarm OOO (Нефрофарм ООО) is based in Russia, with the head office in Dyatkovo. It operates in the Hospitals industry. It was incorporated on January 31, 2005. There are currently 98 (2023) people employed by Nefrofarm OOO (Нефрофарм ООО). From the latest financial highlights, Nefrofarm OOO (Нефрофарм ООО) reported a net sales revenue increase of 24.89% in 2024. Its’ total assets recorded a growth of 0.81%. In 2024, Nefrofarm OOO (Нефрофарм ООО)’s net profit margin increased by 0.56%.

Headquarters
K.Marksa, 2/2, 3
Dyatkovo; Bryansk Oblast; Postal Code: 242600

Contact Details: Purchase the Nefrofarm OOO (Нефрофарм ООО) report to view the information.

Basic Information
Total Employees:
Purchase the Nefrofarm OOO (Нефрофарм ООО) report to view the information.
Registered Capital:
Purchase the Nefrofarm OOO (Нефрофарм ООО) report to view the information.
Financial Auditors:
Purchase the Nefrofarm OOO (Нефрофарм ООО) report to view the information.
Incorporation Date:
January 31, 2005
Key Executives
Purchase this report to view the information.
General Director
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Subsidiaries
Vita OOO
50%
Company Performance
Financial values in the chart are available after Nefrofarm OOO (Нефрофарм ООО) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
24.89%▲
Total operating revenue
24.89%▲
Operating profit (EBIT)
34.43%▲
Net Profit (Loss) for the Period
45.5%▲
Total Assets
0.81%▲
Total Equity
164.21%▲
Operating Profit Margin (ROS)
1.15%▲
Net Profit Margin
0.56%▲
Return on Equity (ROE)
-43.75%▼
Debt/Equity
-1004.33%▼
Quick Ratio
0.36%▲
Cash Ratio
0.22%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo